ClassID:

20464

A61K31/558 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes

Sub-classes:
Recent Application in this class:
#1
20260041696
2026-02-12

IN-SITU PRODUCTION OF ANTI-INFLAMMATORY LIPIDS USING MILK FAT GLOBULES

#2
20250099419
2025-03-27

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

#3
20240343673
2024-10-17

CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS

#4
20240342192
2024-10-17

METHODS OF TREATING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) DYSFUNCTION

#5
20230285411
2023-09-14

DRUG FORMULATION CONTAINING SEPETAPROST

#6
20230190698
2023-06-22

Bicyclic compound and use thereof for medical purposes

#7
20220401455
2022-12-22

BIODEGRADABLE DRUG-POLYMER CONJUGATE

#8
20210346350
2021-11-11

Methods and compositions for treatment of glaucoma and related conditions

#9
20210317066
2021-10-14

Controlled release pharmaceutical formulations

#10
20210308148
2021-10-07

PHARMACEUTICAL USE

#11
20210196728
2021-07-01

Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction

#12
20210196596
2021-07-01

METHOD OF ENHANCING HAIR GROWTH

#13
20210169842
2021-06-10

Bicyclic compound and use thereof for medical purposes

#14
20210077505
2021-03-18

METHOD TO ENHANCE TISSUE REGENERATION

#15
20200390708
2020-12-17

Multilayer beads for pharmaceutical use

#16
20200330479
2020-10-22

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS

#17
20200246237
2020-08-06

METHOD OF ENHANCING HAIR GROWTH

#18
20200101055
2020-04-02

CYP2J2 antagonists in the treatment of pain

#19
20200093781
2020-03-26

Bicyclic compound and use thereof for medical purposes

#20
20200062691
2020-02-27

Controlled release pharmaceutical formulations

#21
20190159988
2019-05-30

METHOD OF ENHANCING HAIR GROWTH

#22
20190125873
2019-05-02

Glucosamine peptide compounds for treating liver metabolic disorders

#23
20190111019
2019-04-18

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

#24
20180169112
2018-06-21

Pharmaceutical use

#25
20180116995
2018-05-03

Bicyclic compound and use thereof for medical purposes

#26
20170369416
2017-12-28

Controlled release pharmaceutical formulations

#27
20170079986
2017-03-23

METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION

#28
20170020890
2017-01-26

PHARMACEUTICAL COMPOSITION COMPRISING FATTY ACID DERIVATIVE

#29
20160354385
2016-12-08

Method to enhance tissue regeneration

#30
20160287551
2016-10-06

Bicyclic compound and use thereof for medical purposes

#31
20160175216
2016-06-23

Method of enhancing hair growth

#32
20160175215
2016-06-23

Method of enhancing hair growth

#33
20150272961
2015-10-01

METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION

#34
20150112079
2015-04-23

Bicyclic compound and use thereof for medical purposes

#35
20140323567
2014-10-30

Controlled release pharmaceutical formulations

#36
20140296345
2014-10-02

Method of enhancing hair growth

#37
20140187642
2014-07-03

Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

#38
20140073676
2014-03-13

Bicyclic compound and use thereof for medical purposes

#39
20130296435
2013-11-07

Method of enhancing hair growth

#40
20130041025
2013-02-14

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

#41
20130030055
2013-01-31

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

#42
20120270945
2012-10-25

METHOD FOR MODULATING CYTOKINE ACTIVITY

#43
20120270931
2012-10-25

Stable pharmaceutical formulations comprising lubiprostone

#44
20120232043
2012-09-13

LUBIPROSTONE FOR OBSTETRICAL OR GYNECOLOGICAL APPLICATIONS

#45
20120202886
2012-08-09

Method of enhancing hair growth

#46
20120122989
2012-05-17

Method of enhancing hair growth

#47
20120122964
2012-05-17

Bicyclic compound and use thereof for medical purposes

#48
20110312996
2011-12-22

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#49
20110065784
2011-03-17

Method for promoting upper gastrointestinal bicarbonate secretion

#50
20110064748
2011-03-17

Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor

#51
20110054016
2011-03-03

Method for modulating claudin mediated functions

#52
20110009370
2011-01-13

Method to enhance tissue regeneration

#53
20100317733
2010-12-16

USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS

#54
20100305203
2010-12-02

METHOD FOR MODULATING CLAUDIN MEDIATED FUNCTIONS

#55
20090286769
2009-11-19

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

#56
20090203659
2009-08-13

Method of enhancing hair growth

#57
20090163584
2009-06-25

Therapeutic agent for renal failure

#58
20080188554
2008-08-07

METHODS OF TREATING AVIAN HYPERTENSION

#59
20080103184
2008-05-01

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS

#60
20080070988
2008-03-20

Method of enhancing hair growth

#61
20080070979
2008-03-20

Method for promoting gastrointestinal bicarbonate secretion

#62
20070282006
2007-12-06

Method of enhancing hair growth

#63
20070203228
2007-08-30

Method for treating chronic obstructive pulmonary disease

#64
20070123569
2007-05-31

THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS

#65
20070123568
2007-05-31

Therapeutic methods using prostaglandin EPagonist components

#66
20060240106
2006-10-26

Enteric coated composition comprising prostaglandin analogs as chloride channel opener

#67
20060106095
2006-05-18

Therapeutic agent for renal failure

#68
20060063830
2006-03-23

Method for treating gastrointestinal disorder

#69
20050272671
2005-12-08

Compositions comprising hepoxilin analogs and their use in the treatment of cancer

#70
20050222252
2005-10-06

Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils

#71
20050222232
2005-10-06

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

#72
20050090556
2005-04-28

Compound for treatment of external secretion disorders

#73
20050049300
2005-03-03

Thromboxane ligands without blood clotting side effects